Background: Left coronary artery arising from the right sinus of Valsalva is an uncommon congenital coro-nary anomaly that seems to be associated with sudden death in young patients.
Background
Coronary artery anomalies (CAAs) are a group of congenital disorders with different manifestations and supposed pathophysiological mechanisms [1] . In literature the overall incidence of CAAs in the general population has been described between 0.3% and 5.64%, which can be explained by the examined inhomogeneous populations and different definitions of CAAs [2] . In case of CAA the interarterial course between the aorta and pulmonary artery is associated with a severe prognosis [1] . In autopsy materials from previously healthy athletes who suffered a sudden death, a right coronary arterial origin from the left coronary sinus and a LCA origin from the right sinus have been described as the most common congenital coronary mal-formations [3] . Sudden death has been sometimes the first manifestation of these abnormalities, whereas CAAs rarely present with symptoms such as angina pectoris, dyspnoe or cardiac arrhythmias. In contrast to CAA with an interarterial course CAA with an extraarterial course are not associated with an increased risk of sudden cardiac death and do not require coronary interventions [1] . We report a case of cardiac arrest associated with Sildenafil ingestion in a patient with a CAA.
Case presentation
A 59-year-old caucasian man was found by his wife collapsed in the bathroom after sexual intercourse. On arrival the rescue team found an unconscious patient with ventricular fibrillation. After single defibrillation and 15 minutes of cardiopulmonary resuscitation spontaneous circulation was restored. His wife reported that the patient has ingested Sildenafil (50 mg) 30 minutes before the cardiac arrest for the first time. Except from a vascular-type erectile dysfunction he had no previous medical history and no familial history of cardiovascular disease or sudden death. The patient did not take a regular medication. After admission in our hospital a 12-lead electrocardiogram showed no signs of significant repolarization abnormalities. There were increases in cardiac enzymes with a troponin I (TNI) of 5.57 ng/ml (reference range < 0.05 ng/ml), a creatinine-kinase (CK) of 3285 U/l (reference range < 180 U/l), a creatine kinase MB (CKMB) of 124 U/l (reference range < 12 U/l) and a CRP of 2.2 mg/dl (reference range < 0.5 mg/dl). 12 hours later TNI and CKMB had decreased to 2.34 U/l and 87 U/l and at 24 hours they had further decreased to 2.09 U/l and 78 U/l, respectively. Echocardiogram showed impaired left ventricular function, ejection fraction was 46 percent. A coronary arteriography ( Figure 1 ) and an angiographic CT scan ( Figure 2 ) were performed. The coronary arteriography revealed an atypical origin of the left coronary artery from the right aortic sinus as well as a distal stenosis of the right coronary artery. Coronary anomaly was confirmed by the angiographic CT scan which showed the interarterial course of the left coronary artery between the pulmonary trunk and the aorta. Due to these findings he was transferred to the cardiac surgery department and coronary artery bypass surgery was performed with the left mammary artery supplying the left anterior descending artery and two venous grafts supplying the ramus circumflexus and right coronary artery. A proximal ligation of the left anterior descending artery was not performed. After 6 months ventricular function had recovered, echocardiography showed an ejection fraction of 54 percent.
CAAs are a group of congenital disorders which rarely present with symptoms such as angina pectoris, dyspnoe or cardiac arrhythmias. Also in our patient the cardiac arrest was the first event and no other symptoms in the past have been observed. Before the event occurred the patient had ingested Sildenafil (50 mg), an oral phosphodiesterase type 5 (PDE5) inhibitor used for the treatment of erectile dysfunction. It has been demonstrated in several studies that the use of sildenafil is not associated with an increased risk for cardiovascular events in a cardiovascular healthy population [4] . However, Patients with known coronary artery disease using PDE5 inhinbitors are at risk of developing myocardial infarction after receiving sildenafil in combination with 
nitrates or calcium antagonists due to prolonged and exaggerated vasodilatation and hypotension [5] . In the present case, the combination of sildenafil-triggered vasodilatation and exercise maybe caused a coronary steal phenomenon following ischemia with lethal arrhythmias. Patients with coronary anomalies usually become symptomatic in their childhood or adolescence. The relatively late age of our patient might indicate that sildenafil as a trigger was necessary to induce a perfusion deficit. Another pathogenetic link in exercise related death in patients with CAAs is suggested to be the compression of the intraarterial coronary artery leading to ischemia in these patients [1] . Due to the high risk of sudden cardiac death in patients with an interarterial course of the aberrant coronary artery reinsertation of the coronary ostia is recommended. In case of additional coronary stenoses bypass surgery should be performed.
In patients with an extraarterial course of the aberrant coronary artery an increased risk of sudden cardiac death could not be observed, coronary interventions are not indicated.
Conclusions
In summary, this case demonstrates that exercise and drugs affecting coronary resistance like Sildenafil might cause ischemia and sudden death in patients with "malignant" coronary artery anomalies and arises the question whether a cardiac screening e.g. by echocardiography might be performed in patients before a Sildenafil therapy is initiated. Of course a link between Sildenafil ingestion and cardiac arrest cannot be conclusively established and a co-occurence of both incidences is possible.
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